Hua Medicine Achieves Development Milestone for HuaTangNing with Bayer Agreement
China-based Hua Medicine (HKG: 2552) has announced the achievement of a significant development milestone for...
Company
MSD’s Welireg Meets Primary Endpoint in Phase III RCC Study but Misses OS Milestone
Merck, Sharp & Dohme (MSD; NYSE: MRK) has revealed that the ongoing Phase III study...
CARsgen Therapeutics Partners with Moderna to Combine CAR-T Therapy with mRNA Cancer Vaccine
China-based CARsgen Therapeutics Holdings Ltd (HKG: 2171) has announced a collaboration agreement with US mRNA...
Simcere Pharmaceutical Group Secures Exclusive Rights to CMAB009 in China
Simcere Pharmaceutical Group Ltd (HKG: 2096) has announced that its subsidiary, Jiangsu Simcere Zaiming Pharmaceutical...
Ezisurg Medical Partners partners with Vathin for Global Disposable Endoscope strategic partnership
Ezisurg Medical Co., Ltd has announced a strategic partnership with Hunan Vathin Medical Instrument Co.,...
Fosun Pharma Adjusts Investment Allocation for 2022 Non-Public Offering Projects
Fosun Pharma (SHA: 600196) has declared adjustments to the investment amounts for some of its...
HutchMed’s Sovleplenib Achieves Primary and Secondary Endpoints in ESLIM-01 Phase III Trial
China-based biopharmaceutical company HutchMed (China) Ltd (NASDAQ: HCM; HKG: 0013) has announced that the pivotal...
Grand Pharmaceutical Group Initiates Phase I Study for Sepsis Treatment APAD
China-based Grand Pharmaceutical Group Limited (HKG: 0512) has announced the enrollment and dosing of the...
HutchMed’s Orpathys Receives Breakthrough Therapy Designation in China for Gastric Cancer
HutchMed (China) Ltd (NASDAQ: HCM; HKG: 0013) has announced that its MET inhibitor, Orpathys (savolitinib),...
Humanwell Healthcare Initiates Phase IIa Clinical Study for IPF Drug HW021199
China-based Humanwell Healthcare (Group) Co., Ltd (SHA: 600079) has announced the commencement of a Phase...
GSK’s RSV Vaccine Arexvy Launches in US Pharmacies Ahead of 2023/24 Season
GlaxoSmithKline (GSK; NYSE: GSK), a UK-based pharmaceutical giant, has announced that its respiratory syncytial virus...
Eyebright Medical Technology Plans GRD Listing on SIX Exchange to Raise RMB 1.4 Billion
Eyebright Medical Technology Co., Ltd (SHA: 688050), a Beijing-based company specializing in ophthalmic medical devices,...
GC Biopharma Presents Data Showing Higher Thrombotic Risk with Roche’s Hemlibra
South Korea’s GC Biopharma (KRX: 006280) has presented evidence suggesting that Roche’s (SWX: ROG) hemophilia...
Moderna Announces Immunogenicity of Updated COVID-19 Vaccine Against New Variants
Moderna (NASDAQ: MRNA) has announced preliminary data indicating that an updated version of its SARS-CoV-2...
Tigermed Establishes International Headquarters in Hong Kong to Accelerate Global Expansion
China-based Contract Research Organization (CRO) Tigermed (SHE: 300347, HKG: 3347) has announced the opening of...
NMPA Approves Rapid Medical Ltd’s Intracranial Thrombectomy Stent for Marketing
The National Medical Products Administration (NMPA) has granted marketing approval to Rapid Medical Ltd for...
Luye Pharma Launches Rykindo in US, a First for Chinese CNS Drug
China-based Luye Pharma Group (HKG: 2186) has announced the official commercial operation of its Rykindo...
CytoMed Therapeutics Partners with CNK Therapeutics for CAR Gene Grafting Technology
Singapore-based cell therapy developer CytoMed Therapeutics Ltd (NASDAQ: GDTC) has announced the signing of a...
CSPC Pharmaceutical Group Receives FDA Approval for NBL-028 Bispecific Antibody Clinical Study
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) has announced that it has received the green...
Aurisco Pharmaceutical Passes US FDA cGMP Inspection at Jiangsu Plant
China-based Aurisco Pharmaceutical (SHA: 605116) has announced the successful completion of a current Good Manufacturing...